Clinical Trials Directory

Trials / Completed

CompletedNCT01136330

DM1 Heart Registry - DM1 Respiratory Registry

Cardiac and Respiratory Prognostic Factors in Patients With Myotonic Dystrophy Type 1

Status
Completed
Phase
Study type
Observational
Enrollment
914 (actual)
Sponsor
Institut de Myologie, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Myotonic dystrophy type 1 (DM1) is the most frequent neuromuscular disease in adults. DM1 patients have an impaired prognosis (mean age of death \<60 years) due to cardiac and respiratory complications. Our primary objective was to identify cardiac and respiratory prognostic factors in DM1.

Detailed description

1. Patients with genetically proven DM1 who were admitted in Pitié Salpêtrière Hospital from 2000 and 2010 will be identified. These patients systematically underwent neurological, cardiac and respiratory investigations. 2. Baseline medical and genetic information will be entered in a dedicated database, including cardiac and respiratory investigations. 3. The occurence of severe cardiac and respiratory adverse events will also be collected. 4. Statistical analysis will be performed to look for correlations between baseline patient characteristics and cardiac or respiratory adverse events during follow up.

Conditions

Timeline

Start date
2010-05-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2010-06-03
Last updated
2012-02-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01136330. Inclusion in this directory is not an endorsement.

DM1 Heart Registry - DM1 Respiratory Registry (NCT01136330) · Clinical Trials Directory